Frontiers in Cellular and Infection Microbiology (Jun 2022)

Nomogram Model for Prediction of SARS-CoV-2 Breakthrough Infection in Fujian: A Case–Control Real-World Study

  • Tianbin Chen,
  • Tianbin Chen,
  • Yongbin Zeng,
  • Yongbin Zeng,
  • Di Yang,
  • Wenjing Ye,
  • Jiawei Zhang,
  • Jiawei Zhang,
  • Caorui Lin,
  • Caorui Lin,
  • Yihao Huang,
  • Yucheng Ye,
  • Yucheng Ye,
  • Jianwen Li,
  • Qishui Ou,
  • Qishui Ou,
  • Jinming Li,
  • Can Liu,
  • Can Liu

DOI
https://doi.org/10.3389/fcimb.2022.932204
Journal volume & issue
Vol. 12

Abstract

Read online

SARS-CoV-2 breakthrough infections have been reported because of the reduced efficacy of vaccines against the emerging variants globally. However, an accurate model to predict SARS-CoV-2 breakthrough infection is still lacking. In this retrospective study, 6,189 vaccinated individuals, consisting of SARS-CoV-2 test-positive cases (n = 219) and test-negative controls (n = 5970) during the outbreak of the Delta variant in September 2021 in Xiamen and Putian cities, Fujian province of China, were included. The vaccinated individuals were randomly split into a training (70%) cohort and a validation (30%) cohort. In the training cohort, a visualized nomogram was built based on the stepwise multivariate logistic regression. The area under the curve (AUC) of the nomogram in the training and validation cohorts was 0.819 (95% CI, 0.780–0.858) and 0.838 (95% CI, 0.778–0.897). The calibration curves for the probability of SARS-CoV-2 breakthrough infection showed optimal agreement between prediction by nomogram and actual observation. Decision curves indicated that nomogram conferred high clinical net benefit. In conclusion, a nomogram model for predicting SARS-CoV-2 breakthrough infection based on the real-world setting was successfully constructed, which will be helpful in the management of SARS-CoV-2 breakthrough infection.

Keywords